Sesame Review: Is the Pay-Per-Visit Model Worth It for Ozempic?

What is Sesame, exactly, and how do I actually get an Ozempic prescription through it?

Sesame launched in 2018 with a simple pitch: cut insurance out of routine doctor visits, show the real cash price upfront, and let patients book directly with independent, state-licensed clinicians. It's raised roughly $75 million doing that, including a $27 million Series B round led by GV — Google's venture arm — back in 2022, alongside Virgin Group and General Catalyst. That funding history matters here mostly as a legitimacy signal: this is a backed, professionally run marketplace, not a two-person compounding operation with a slick landing page.

Where it gets less straightforward is Ozempic specifically. Sesame's own medication page for Ozempic doesn't lead with a one-off visit — it leads with Success by Sesame, a dedicated weight-loss and GLP-1 subscription that starts around $59 a month. Book that program, complete an intake about your weight, health history, and goals, and a provider reviews your case, typically without a live video call required, though that depends on the individual clinician. If a GLP-1 makes sense, they send an e-prescription, and you decide where it gets filled. You can, in theory, still book a single general visit — a prescription refill or primary-care consult at Sesame's usual $37-to-$79 range — and simply ask about a GLP-1 there instead. But the platform's own weight-loss pages are built around the subscription, not the one-off visit, which is worth knowing before you assume Sesame works the same way for Ozempic as it does for a sinus infection.

How much does a Sesame visit really cost — and does that include the Ozempic itself?

No, and this is the single most important thing to understand before you compare Sesame's price to anything else in this category. There are two completely separate bills.

• Success by Sesame subscription: $99/mo month-to-month, $79/mo on a 6-month term ($474 total), or $59/mo on an annual term ($708 total)
• That subscription covers video visits, unlimited messaging, ongoing provider access, and labs where your state allows it — not the drug
• A standalone general visit, outside the dedicated program: $37 to $79, one time, no recurring charge
• The medication is always a third, separate transaction, paid to whichever pharmacy fills it

For Ozempic itself, Sesame routes uninsured patients to NovoCare Pharmacy's own cash-pay program: $199 a month for your first two fills, then $349 a month for the 0.25, 0.5, and 1 mg doses, or $499 a month at the 2 mg dose. Wegovy runs similarly — $149 or $299 a month for the oral pill depending on dose, or $199 for two months then $349 a month for the injectable pen. Zepbound and Foundayo (Lilly's newer oral orforglipron) are priced separately through Lilly's own program, from $149 up to $698 a month depending on drug and dose. None of those numbers include the Sesame subscription fee sitting on top of them.

Is Sesame legit? Who are the doctors, and is this actually safe?

Sesame is a real, long-operating company, not a scam. It's raised institutional venture funding from recognizable names, reports a 4.6-out-of-5 Trustpilot rating across roughly 4,500 reviews, and the most repeated praise in those reviews is fast scheduling and thorough, professional providers. The doctors and nurse practitioners on the platform are independent, state-licensed clinicians who set their own hours and, for many services, their own prices — Sesame is the booking layer and payment processor, not their employer.

The less flattering side of the record: the Better Business Bureau's own profile lists Sesame with a B- rating and marks it 'not BBB accredited,' with 17 complaints closed over the past three years. Recurring themes in both BBB complaints and lower Trustpilot reviews center on billing — patients describing charges continuing after a cancellation request, or the 28-day (not calendar-month) subscription cycle catching them off guard — plus occasional reports of an unresponsive assigned provider. No FDA warning letter or active lawsuit specific to Sesame turned up in this research pass, though that search wasn't exhaustive enough to treat as the final word. The honest read: a legitimate, well-funded company with a genuinely decent reputation and a real, documented pattern of billing friction — both things can be true at once.

Will Sesame actually prescribe Ozempic for weight loss, or only for diabetes?

Sesame's own materials are direct about the regulatory reality here, which is more than some competitors manage. Ozempic is FDA-approved specifically for adults with type 2 diabetes; using it for weight loss alone is an off-label decision a provider makes case by case, the same clinical judgment call any doctor makes when prescribing outside a drug's labeled indication. Sesame's site states this plainly rather than glossing over it.

If weight loss is genuinely your only goal, Sesame's Success by Sesame program leans toward the medications that actually carry the FDA's weight-management indication instead — Wegovy (also semaglutide, just approved for weight loss specifically), Zepbound (tirzepatide), and Foundayo (orforglipron, Lilly's newer oral GLP-1). A provider deciding between Ozempic and Wegovy for you isn't picking a stronger or weaker drug — chemically, Ozempic and Wegovy are the same molecule at different approved doses — they're picking the one whose FDA label actually matches your goal.

Where do I fill the prescription, and what will the pharmacy actually charge me?

Sesame is explicit that it doesn't dispense or ship medication itself. Once a provider approves your prescription, you pick where it goes: same-day pickup at your regular local pharmacy, or a mail-order option for home delivery. For brand-name GLP-1s, that mail-order option is usually the manufacturer's own cash-pay pharmacy — NovoCare for Ozempic and Wegovy, LillyDirect for Zepbound and Foundayo — which is also where the pricing quoted above actually comes from.

One thing worth flagging plainly: compounded semaglutide is not currently offered through Sesame. The platform's medication page says so directly, framing compounded product as inconsistent in strength and quality control compared to FDA-approved versions. That's a real difference from providers like Henry Meds or Mochi Health, which built their entire pricing model around compounded GLP-1s specifically because they're cheaper than brand name. If you're hoping to route a Sesame prescription to a compounding pharmacy yourself, you can — Sesame will send an e-prescription anywhere you ask — but you're on your own for finding and vetting that pharmacy; Sesame doesn't name or steer toward one. For the full picture of that route generally, see compounded Ozempic.

Does Sesame require insurance, or can I use it cash-pay?

Cash-pay is the whole point of the general marketplace — Sesame's pitch is a transparent price shown before you book, with nothing billed to insurance for the visit itself. That holds for Success by Sesame too: the subscription is a flat cash fee regardless of what coverage you have.

The medication is a different story. Sesame's providers can help submit prior-authorization paperwork if you want to try billing your insurance for Ozempic, Wegovy, or a comparable GLP-1, and if that's approved, the drug itself can run as low as $25 a month — a fraction of the self-pay price. Sesame's own materials note the obvious caveat: Medicare and Medicaid typically don't cover GLP-1 medications prescribed for weight loss specifically, even when a commercial plan might.

What states does Sesame operate in, and who is the doctor I'll actually see?

Sesame operates in all 50 states plus D.C., though which specific specialties and how many providers are available narrows by location — a rural state may have a thinner bench of weight-loss-focused clinicians than California or New York. Because Sesame is a marketplace rather than a staffed clinic, you're not guaranteed the same provider from visit to visit unless you specifically book with them again, and provider bios, ratings, and individual pricing are visible before you choose who to see — closer to picking a specialist off a directory than being assigned one.

What's the catch — no ongoing care coordination, no compounded fulfillment, no membership perks?

The catch isn't hidden, but it is easy to miss if you only read Sesame's homepage. The brand's whole identity is built on "no subscription, no membership, cash price shown upfront" — and that's genuinely true of urgent care, dermatology, and most one-off visits on the platform. It is not quite true of the GLP-1 program specifically, where Success by Sesame is itself a recurring monthly charge, just one that happens to exclude the medication rather than include it the way Henry Meds or Mochi Health's bundled pricing does.

• Success by Sesame is a subscription, not a one-time fee, despite Sesame's general no-subscription positioning
• The subscription price never includes the drug — you're always managing a second, separate pharmacy bill
• No compounded GLP-1 option, and no named compounding pharmacy partner if you want one
• Billing runs on a 28-day cycle rather than a calendar month, which shows up as a recurring point of confusion in reviews
• No dedicated care-coordination team — you're the one tracking refill timing, dose changes, and which pharmacy has your prescription

How does Sesame compare to Henry Meds, Mochi Health, PlushCare, or Push Health for getting Ozempic?

Every one of these four handles the medication question differently, and that's really the whole comparison.

Henry Meds — $249–$449/mo, all-in, compounded only

Henry Meds bundles the provider visit, the compounded medication, and shipping into one flat monthly price with no separate membership. That makes it simpler to budget than Sesame, and usually cheaper than Sesame's combined subscription-plus-brand-name total — but Henry Meds doesn't offer FDA-approved brand-name GLP-1s at all, only compounded semaglutide and tirzepatide. If brand name matters to you, or you want your insurance to have any shot at covering the drug, Sesame gives you that option and Henry Meds doesn't. Full breakdown at the Henry Meds cost guide.

Mochi Health — per-dose pricing, cheapest early in titration

Mochi moved its compounded medication to per-dose pricing in August 2026: semaglutide runs $60 to $99 a month and tirzepatide $90 to $199 a month depending on your prescribed dose, plus a flat $79-a-month membership — landing between roughly $139 and $278 a month all-in. At a starting dose, that's well below anything Sesame can offer, since Sesame's brand-name route starts at $199 a month for the drug alone before the subscription is even added. Even at a full maintenance dose, Mochi's combined total is usually still lower than Sesame's subscription-plus-NovoCare bill. What Mochi doesn't offer is FDA-approved brand-name medication or a real path to insurance coverage — that's the tradeoff for the lower price. See the Mochi Health cost guide for the dose-by-dose numbers.

PlushCare — the closest structural cousin to Sesame

PlushCare is the provider on this list that behaves most like Sesame: an insurance-first, primary-care-style telehealth company that also routes uninsured patients to NovoCare Pharmacy at a comparable cash price to what Sesame quotes. The real difference is depth of insurance integration — PlushCare is explicitly in-network with major carriers like Aetna, Blue Cross Blue Shield, and Cigna for the visit itself, while Sesame's model is cash-first with insurance handled after the fact through prior authorization. If you're insured and want the visit itself billed to your plan, PlushCare is built for that in a way Sesame isn't. Details at the PlushCare cost guide.

Push Health — the truest marketplace-to-marketplace comparison

Push Health is Sesame's nearest philosophical relative: a pay-per-request marketplace, $65 to $200 per consult, that explicitly does not include the medication and lets you route the prescription to any pharmacy you choose, compounded or brand name. The difference is that Push Health never pretends to be anything but a one-off visit — there's no subscription layer at all — while Sesame's GLP-1 program specifically adds one. See the full Push Health cost guide.

Who is Sesame actually a good fit for, and who should choose a bundled GLP-1 telehealth brand instead?

Sesame makes the most sense for a woman who wants a real doctor's evaluation and a legitimate e-prescription without joining a weight-loss-specific subscription brand — someone comfortable picking her own pharmacy, comparing NovoCare's or LillyDirect's cash price herself, and possibly pursuing her own insurance prior authorization. It's also a reasonable choice if you specifically want brand-name Ozempic, Wegovy, or Zepbound rather than a compounded version, since Sesame doesn't offer compounded product at all.

It's a weaker fit if you want one flat monthly number that already includes the medication, or a single company to call when something goes wrong with a shipment or a refill. For that kind of simplicity, Henry Meds or Mochi Health will genuinely serve you better, even though their all-in total often lands lower than Sesame's true combined cost once the subscription and the brand-name drug are added together.

Is there a coupon or way to lower the cost?

There's no Sesame-specific promo code circulating, and the platform doesn't run its own discount program for the subscription. The real savings come from the manufacturer side, and from how you structure your Sesame commitment.

• Commit to the annual Success by Sesame term rather than paying month to month — $59/mo instead of $99/mo, a meaningful difference over a year
• Use NovoCare's or LillyDirect's introductory pricing on your first fills — $199/mo for the first two months on Ozempic or Wegovy — before the standard rate kicks in
• Ask your Sesame provider to submit a prior-authorization request to your insurer before assuming you're stuck at the cash price
• Confirm whether your HSA or FSA can cover the Sesame subscription fee itself, not just the medication, which effectively discounts it by your marginal tax rate

None of these levers make Sesame's GLP-1 path as cheap as a compounded-first provider's flat monthly rate. What they do is bring the brand-name route closer to affordable for a woman who specifically wants FDA-approved medication, real insurance-adjacent flexibility, and the freedom to pick her own pharmacy over a bundled subscription that decides all of that for her.